Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 96,534 shares at $210.41 ($20.4M) on 2019-11-19, disclosed to the SEC on 2019-11-21.
Open-market sale of $20.4M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.41 | 62,886 | $13.2M | 65.0% |
| 2 | $211.43 | 23,033 | $4.9M | 23.9% |
| 3 | $212.75 | 10,615 | $2.3M | 11.1% |
| Total | $210.91 avg | 96,534 | $20.4M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |